Даваа–Баасан 08:30–20:00 · Бямба 09:00–16:00
Now showing 1 - 2 of 2
  • Some of the metrics are blocked by your 
    Item type:Publication,
    Effect of Erdene urel on Microglia / Macrophage Distribution and Inhibition of Inflammatory Response after Brain Ischemia in Rats
    (Mongolian National University of Medical Sciences, 2020-04-01)
    Hu Yu Rong
    ;
    Khaliunaa Tumurbaatar
    ;
    B. Gansukh
    ;
    ;
    Chimedragchaa Chimedtseren
    Objectives: We studied the effect of Erdene urel on microglia/macrophage M1/M2 distribution and neuroinflammation using a cerebral ischemia-reperfusion injury model in rats. Methods: The middle cerebral artery occluded by thread occlusion, followed by reperfusion at 90 minutes after ischemia. The injury was studied at 1, 3, and 7 days after brain ischemia, and the neurological score was graded, after that, the brain tissue was collected by decollation. The phenotypes of M1 and M2 were detected by Iba1 and Arg-1 immunofluorescence, and the expressions of (TNF-D), (IL-1E), (IL-6), and (IL-10) were detected by ELISA. Result: The immunofluorescence showed that compared with the sham-operated group, the microglia/ macrophage (Iba1) in the ischemic area of the control group’s rats with middle cerebral artery occlusion and to which reperfusion was performed for 1, 3 and 7 days was increased (p<.05) and the number of M2 (Arg-1) (p<.05) was reduced. One day after reperfusion, the Erdene urel and nimodipine groups did not differ from the control group. However, after 3 and 7 days, the microglia/macrophage (Iba1) (p<.05) in the ischemic area of Erdene urel and nimodipine groups was reduced, while M2 (Arg-1) (p<.05) was increased. Conclusion: Erdene urel is likely capable of promoting the transformation of activated microglia/macrophages from M1 to M2.
  • Some of the metrics are blocked by your 
    Item type:Publication,
    The Chronic and Acute Toxicity of Traditional Medicines Containing Terminalia chebula
    (Korean Pharmacopuncture Institute, 2023-03)
    Arongqiqige
    ;
    ;
    Song, Wang
    ;
    Xi, Wei Cheng
    ;
    OBJECTIVES: Terminalia chebula, the main ingredient of Altan Arur 5, has been used for many years in traditional medicine. This medicine is more effective than other drugs and is used to treat chronic gastritis and gastrointestinal disorders such as peptic ulcers and esophageal reflux. Other ingredients of Altan Arur 5 are Punica granatum (pomegranate), tulip seeds, black balm, and excreta of Trogopterus xanthipes. The main ingredients of T. chebula are antibacterial and analgesic in traditional medicine. Despite having been used for many years and although many studies have been conducted on the beneficial effects of this medicine and its ingredients, the toxicity of Altan Arur 5 has not yet been elucidated. Therefore, we aimed to study the toxicity of Altan Arur 5 to ensure that it is safe to use. METHODS: Acute and chronic toxicity of Altan Arur 5 were assessed in 10 Kunming mice and 8 Sprague-Dawley rats, respectively, in different doses. In the acute toxicity study, Altan Arur 5 was orally administered to Kunming mice in doses of 12 g/kg, 24 g/kg, and 48 g/kg for 14 days. In the chronic toxicity study, it was orally administered to Sprague-Dawley rats in doses of 1.25 g/kg, 2.5 g/kg, and 5 g/kg for 12 weeks. RESULTS: No significant differences were observed in the relative organ weights for mice treated with Altan Arur 5 compared with those in the control group. Furthermore, no macro- or microstructural changes were noted in the organs of any group. CONCLUSION: Our toxicity testing revealed that the traditional medicine Altan Arur 5 has no toxic effects in vivo.